Nyaradzo Mgodi

机构：University of Zimbabwe · ORCID：0000-0002-3085-5259

发表论文 151 篇 · 总被引 6375 次 · h-index 32

代表论文

• Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 (2025 · Journal of the International AIDS Society · 被引 18)
• Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial (2025 · The Lancet HIV · 被引 13)
• An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP — Essential or Irrelevant? (2025 · New England Journal of Medicine · 被引 9)
• Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial (2025 · The Lancet HIV · 被引 8)
• Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study (2025 · EClinicalMedicine · 被引 5)
• Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study (2025 · The Lancet HIV · 被引 3)